Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$1.14 - $2.97 $968 - $2,524
850 New
850 $1,000
Q3 2023

Oct 11, 2023

BUY
$2.49 - $11.85 $144 - $687
58 Added 72.5%
138 $0
Q2 2023

Aug 03, 2023

SELL
$6.39 - $28.58 $63 - $285
-10 Reduced 11.11%
80 $1,000
Q1 2023

Apr 28, 2023

BUY
$17.7 - $33.24 $1,593 - $2,991
90 New
90 $2,000
Q2 2022

Jul 28, 2022

SELL
$9.03 - $21.55 $90 - $215
-10 Closed
0 $0
Q1 2022

Apr 21, 2022

SELL
$15.0 - $22.83 $285 - $433
-19 Reduced 65.52%
10 $0
Q4 2021

Jan 31, 2022

SELL
$20.12 - $35.09 $1,589 - $2,772
-79 Reduced 73.15%
29 $1,000
Q4 2020

Jan 27, 2021

BUY
$42.46 - $56.58 $4,585 - $6,110
108 New
108 $5,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $8.41M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.